# OnCo record anbl0032 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/anbl0032/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "anbl0032", "NCT00026312" ;
  schema:name "COG ANBL0032"@en ;
  schema:description "The trial that made anti-GD2 immunotherapy standard for children with high-risk neuroblastoma, improving survival by about 20 points."@en ;
  schema:url <https://onco.cc/trials/anbl0032/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00026312> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2001-10-26" ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma/>, <https://onco.cc/cancers/neuroblastoma-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/gd2/> ;
  onco:drugs <https://onco.cc/drugs/dinutuximab/>, <https://onco.cc/drugs/isotretinoin/> ;
  onco:companies <https://onco.cc/companies/childrens-oncology-group/> ;
  onco:people <https://onco.cc/people/alice-yu/>, <https://onco.cc/people/julie-park/> .